Ph2 RO7198457 CRC ctDNA+ Post Resection
Phase II/III Clinical Trial
A multi-site open-label Phase II randomized controlled trial to compare the efficacy of RO7198457 versus watchful waiting in resected Stage II (high risk) and Stage III colorectal cancer patients who are ctDNA positive following resection (BNT122-01)